IMEL BIOTHERAPEUTICS
Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders. It uses a proprietary mitochondrial replaced cells technology, helping physicians to treat multiple patients with mitochondrial genetic or age-related disorders. The company was founded in 2019 and is based in Waltham, Massachusetts.
IMEL BIOTHERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.imelbiotx.com
Status:
Active
Total Funding:
15.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud OpenResty Google Adsense
Similar Organizations
Athos Therapeutics
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimerโs disease and other neurodegenerative disorders.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.imelbiotx.com
- Host name: 80.178.112.44.adsl.012.net.il
- IP address: 80.178.112.44
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Imel Biotherapeutics"
IMEL Biotherapeutics - Targeting mitochondrial dysfunction
Kyoko has over 20 years business experience in drug discovery in the pharmaceutical industry, patent practice at a patent firm and tech transfer at Technology Licensing Organization (TLO). โฆSee details»
Imel Biotherapeutics - Crunchbase Company Profile & Funding
Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders. It uses a proprietary mitochondrial replaced cells technology, helping physicians to treat โฆSee details»
Imel Biotherapeutics Company Profile | Management and
[email protected]: Imel Biotherapeutics Top Competitors. Company Employees Revenue Top technologies; AVROBIO. 13: $54.4 M: Jaguar Gene Therapy. 33: $6.3 M: Code Bio. 10: $1.5 โฆSee details»
Imel Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.imelbiotx.com. Last update 01 Nov 2024See details»
imelbiotx.net
Imelbiotx.netSee details»
Imel Biotherapeutics Inc Overview | SignalHire Company Profile
Imel Biotherapeutics Inc headquarters is in Waltham, Massachusetts. Imel Biotherapeutics Inc is in the sectors of: Biotech. To connect with Imel Biotherapeutics Inc's employee register on โฆSee details»
Imel Biotherapeutics Inc | LinkedIn
IMEL develops cell-based therapies to restore mitochondrial function for the treatment of genetic diseases and age-related indications. Our unique approach enables replacing the โฆSee details»
Imel Biotherapeutics, Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Imel Biotherapeutics, Inc of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
IMEL Biotherapeutics - PitchBook
IMEL Biotherapeutics General Information Description. Developer of cell-based therapies designed to treat patients with mitochondrial disorders. The company uses a proprietary โฆSee details»
Imel Biotherapeutics - Overview, News & Similar companies
Www.imelbiotx.com. Revenue <$5 Million. Industry Drug Stores & Pharmacies Retail . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Imel Biotherapeutics. โฆSee details»
Imel Biotherapeutics Inc Overview - Salary.com
Discover essential details about Imel Biotherapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Imel Biotherapeutics, Inc.:Company Profile & Technical Research ...
Imel Biotherapeutics, Inc. is a company that provides Mitochondrial disease and more. Imel Biotherapeutics, Inc. is headquartered in United States Massachusetts.See details»
Nextsource | Company Profile | Imel Biotherapeutics
Explore the company profile of Imel Biotherapeutics (imelbiotx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Company Information - RocketReach
The most common Imel Biotherapeutics Inc email format. is [first] (ex. [email protected]), which is being used by 100.0% of Imel Biotherapeutics Inc work email addresses. Imel โฆSee details»
How much do Imel Biotherapeutics Inc employees make?
The average annual salary of Imel Biotherapeutics Inc is estimated to be approximate $102,242 per year. The majority pay is between $89,913 to $115,610 per year. Visit Salary.com to find โฆSee details»
Mitochondrial dysfunction mechanism dysfunction indications
Feb 22, 2022 Contact info: Dori Pelled, Ph.D - COO +972 5 4450 6092 [email protected] IMELโs products: Autologous mitochondrial replaced cells (MirC) for cell-based therapy IMELโs โฆSee details»
IMEL in a nutshell Mitochondrial diseases Mitochondrial disorders
+972 5 4450 6092 [email protected] IMEL employs routine autologous stem cells transplantation method Adding a patented ex vivo step (03) to the routine transplantation โฆSee details»
PRESS RELEASE - ใคใกใซๅต่ฌๆ ชๅผไผ็คพ
E-mail : [email protected] Taro Inaba, Representative Director at Imel Therapeutics, Inc. E-mail : [email protected] . Created Date: 5/26/2021 5:56:16 AM ...See details»
Event Archives - IMEL Biotherapeutics
Careers. Would you like to join our growing team?See details»
MatchBio
The poor-sensitivity of chimeric-antigen receptors has been a significant barrier to CAR-T cell therapy reaching its full potential. MatchBio aims to solve this and unleash the full power of โฆSee details»